Home > Insider Trading > Filing (0001120295-13-000084)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1120295	Ixia	XXIA	Instruments For Meas & Testing Of Electricity & Elec Signals (3825)	954635982

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1418363	Alan Grahame	C/O Ixia 26601 West Agoura Road Calabasas CA 91302	Sr. Vp, Worldwide Sales	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-02-07	4,500	$0.00	55,150	No	4	A	Direct
Common Stock	Acquisiton	2013-02-08	20,000	$10.30	75,150	No	4	M	Direct
Common Stock	Disposition	2013-02-08	20,000	$20.89	55,150	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2013-02-07	13,500	$0.00	13,500	$20.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,500		2020-02-07	No	4	A	Direct

Footnotes

Restricted Stock Units for 4,500 shares vest and shares will be issued in 16 equal quarterly installments with the first installment vesting on 5/15/13 and one additional installment vesting on the 15th day of the second calendar month of each of the fifteen calendar quarters thereafter. Each Restricted Stock Unit represents the right to receive one share of Ixia Common Stock to be issued and delivered upon the applicable vesting date.
Amendment is being filed to correct (a) the number of securities reported in each of Column 4 (Securities Acquired (A)) and Column 5 (Amount of Securities Beneficially Owned Following Reported Transaction (s)) of Table I and (b) the number of securities reported in each of Column 5 (No. of Derivative Securities Acquired (A)), Column 7 (Amount of Underlying Securities), and Column 9 (No. of Derivative Securities Beneficially Owned Following Reported Transaction(s)) of Table II. Subsequent reports filed on each of February 15, 2013, February 21, 2013, March 5, 2013 and March 7, 2013 also incorrectly stated the balance in Column 5 of Table I which should be decreased by 8,000 shares in each line item in each report.
Option to purchase 13,500 shares vests and becomes exercisable in sixteen equal quarterly installments commencing 6/30/13.